Cognis PharmaLine(TM) achieves kosher certification
Kosher certification is an essential purchasing criterion for millions of consumers of food and healthcare products around the world, particularly for adherents of the Jewish faith. Kosher certification is also seen as a sign of quality by many consumers, especially in the USA. To help manufacturers of cough syrups, toothpastes and other orally administered products serve this market, Cognis has expanded its portfolio of kosher certified excipients to include PharmaLine(TM) . This range of high-purity oleochemical-derived excipients is suitable for many different pharmaceutical applications and includes tableting aids, drug delivery agents, and customized excipients.
A total of 56 PharmaLine(TM) products have been certified as kosher for passover by a representative of Kosher Germany, a respected certification body. They are produced under strict supervision, and their kosher status can be referred to in manufacturers' marketing activities. Furthermore, only plant derived and synthetic raw materials are used during production. Comments Thomas Rosen, Global Product Line Manager Pharmaceuticals & Healthcare: "Certification adds further value to our excipients and is one more way that we are helping our customers to meet the demanding requirements of today's pharmaceutical and consumer healthcare markets."
BASF Personal Care and Nutrition GmbH
Cognis is a worldwide supplier of innovative specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability. The company employs about 7,600 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, textiles, as well as agriculture and mining. The subsidiary Pulcra Chemicals offers specialized chemical products and process expertise to customers in the fiber, textile, and leather industries. Cognis also holds a 50-percent stake in the joint venture Cognis Oleochemicals, one of the world's leading manufacturers of oleochemicals.
Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2007, Cognis recorded sales of about 3.52 billion euros and an Adjusted EBITDA (operating result) of 410 million euros.